Skip to main content
. 2020 Jun 26;34(10):e23442. doi: 10.1002/jcla.23442

FIGURE 2.

FIGURE 2

MiR‐10b was low expressed in pancreatic ductal adenocarcinoma (PDAC) and contributed to the poor survival of PDAC. A, MiR‐10b was weak expressed in ASPC‐1, and T3M4 compare to it in HPDE6‐C7 by RT‐PCR. B, MiR‐10b was overexpressed in PDAC tissue. C and D, The survival curves showed the expression of miR‐10b contributed to disease‐free survival (DFS) and overall survival (OS) in 180 patients. Data are shown as mean ± SD, n = 3. The Student's t test assesses statistical data significance. *P < .05, **P < .01